A pragmatic, multicentre, placebo-controlled, 3-arm, double-blinded, randomised controlled trial, incorporating an internal pilot, to determine the role of bronchodilators in preventing exacerbations of bronchiectasis

Background Bronchiectasis is a long-term lung condition associated with bronchial dilatation, chronic inflammation and infection. Treatment is often empirical or extrapolated from other lung conditions, for example the use of inhaled therapies licensed for use in asthma or chronic obstructive pulmon...

Description complète

Détails bibliographiques

Auteurs principaux:	Nina Wilson, Miranda Morton, Tara Homer, Ann Breeze Konkoth, Richard Joyce, Anneka Kershaw, Hazel Wilde, Alison Liddle, James Wason, Laura Ternent, Maria Allen, Robert Lord, John Steer, Graham Devereux, James D Chalmers, Adam T Hill, Charles S Haworth, John R Hurst, and Anthony De Soyza
Format:	Artigo
Langue:	Inglês
Publié:	NIHR Journals Library 2026-02-01
Collection:	Health Technology Assessment
Sujets:	humans adult bronchiectasis bronchodilator agents fluticasone furoate muscarinic antagonists inhaled corticosteroid prospective studies
Accès en ligne:	https://doi.org/10.3310/GGCC1111
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!